Climb Bio, Inc.
For the period ended Dec 31, 2024. Filed Mar 25, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 25, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Climb Bio, Inc. | ||
| Date: March 25, 2025 | By: | /s/ Aoife Brennan |
|---|---|---|
| Aoife Brennan, M.B., Ch.B. | ||
| President and Chief Executive Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Aoife Brennan | President and Chief Executive Officer | March 25, 2025 |
| Aoife Brennan, M.B., Ch.B. | (Principal Executive Officer) | |
| /s/ Brett Kaplan | Chief Operating Officer | March 25, 2025 |
| Brett Kaplan, M.D. | (Principal Financial Officer) | |
| /s/ Emily Pimblett | SVP Finance and Chief Accounting Officer | March 25, 2025 |
| Emily Pimblett | (Principal Accounting Officer) | |
| /s/ Douglas E. Williams | Director | March 25, 2025 |
| Douglas E. Williams, Ph.D. | (Chairman) | |
| /s/ Andrew Levin | Director | March 25, 2025 |
| Andrew Levin, M.D., Ph.D. | ||
| /s/ Judith Dunn | Director | March 25, 2025 |
| Judith Dunn, Ph.D. | ||
| /s/ Adam Rosenberg | Director | March 25, 2025 |
| Adam Rosenberg | ||
| /s/ Simon Tate | Director | March 25, 2025 |
| Simon Tate | ||
| /s/ Stephen Thomas | Director | March 25, 2025 |
| Stephen Thomas, Ph.D. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.